What is twig?
Headquartered in the King's Cross district of London, twig operates as a specialized bioengineering company and AI-driven ingredient development platform. The firm sits at the intersection of synthetic biology and machine learning, utilizing proprietary algorithms to optimize the discovery and production of novel ingredients. By digitizing the development process, twig addresses critical inefficiencies in traditional ingredient sourcing and manufacturing, offering a scalable solution for industries ranging from food technology to sustainable materials. Its market position is defined by its ability to bridge the gap between complex biological research and commercial-scale application, positioning it as a key player in the future of sustainable industrial inputs.
How much funding has twig raised?
twig has raised a total of $3.6M across 1 funding round:
Other Financing Round
$3.6M
Other Financing Round (2023): $3.6M with participation from Gaingels, Seedcamp, and Project A Ventures
Key Investors in twig
Gaingels
Gaingels is a prominent investment syndicate focused on supporting LGBTQ founders and inclusive teams, providing capital and board-level advisory services across various high-growth sectors.
Seedcamp
Seedcamp is a leading European venture capital firm that provides early-stage investment and mentorship to ambitious founders, helping them scale from initial concepts to global market leaders.
Project A Ventures
Project A Ventures is a Berlin-based early-stage VC firm that combines capital with a large platform team of functional experts to support tech companies in product development, marketing, and business intelligence.
What's next for twig?
With this major enterprise-level funding secured, twig is well-positioned to transition from its current development phase into a period of aggressive commercial expansion. The strategic roadmap likely involves scaling its AI platform to accommodate a broader range of ingredient profiles and strengthening its intellectual property portfolio. Furthermore, the company is expected to leverage its recent capital to deepen its partnerships with global manufacturers, effectively shortening the time-to-market for its bio-engineered solutions. As the firm matures, the focus will shift toward operational excellence and the establishment of a robust supply chain, ensuring that its technological advancements can be deployed at a global scale to meet the rising demand for sustainable and high-performance ingredients.
See full twig company page
